EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

J.S. Smolen, R. Landewe, F.C. Breedveld, M. Buch, G. Burmester, M. Dougados, P Emery, C. Gaujoux-Viala, L. Gossec, J. Nam, S. Ramiro, K. Winthrop, M.P.T. de Wit, D. Aletaha, N. Betteridge, J.W.J. Bijlsma, M. Boers, F. Buttgereit, B. Combe, M. CutoloN. Damjanov, J.M.W. Hazes, M. Kouloumas, T.K. Kvien, X. Mariette, K. Pavelka, P.L.C.M. van Riel, A. Rubbert-Roth, M. Scholte-Voshaar, D.L. Scott, T. Sokka-Isler, JB Wong, D. van der Heijde

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)492-509
JournalAnnals of the Rheumatic Diseases
Volume73
Issue number3
DOIs
Publication statusPublished - 2014

Cite this